Institutional investors hold a majority ownership of PDLI through the 95.82% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $8.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BANK OF AMERICA, NA (PRIVATE BAN... Bought 1.7 Million shares of PDL BioPharma Inc
QS INVESTORS LLC Bought 1.5 Million shares of PDL BioPharma Inc
MORGAN STANLEY & CO. LLC Bought 1.4 Million shares of PDL BioPharma Inc